Home > Boards > US OTC > Biotechs > Titan Pharmaceuticals Inc. (TTNP)

It’s happening

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
blast1977 Member Profile
 
Followed By 2
Posts 618
Boards Moderated 0
Alias Born 11/21/14
160x600 placeholder
Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement PR Newswire (US) - 10/12/2021 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:48:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2021 5:18:30 PM
Titan Pharma reports positive TP-2021 implant results in animal model of chronic pruritus Seeking Alpha - 6/23/2021 8:32:57 AM
Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus PR Newswire (US) - 6/23/2021 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 4:13:01 PM
Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K PR Newswire (US) - 3/31/2021 4:30:00 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/31/2021 4:08:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 6:38:07 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 6:32:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 6:27:46 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/8/2021 6:05:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/4/2021 2:25:04 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 2/4/2021 6:11:33 AM
Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development P... PR Newswire (US) - 2/1/2021 7:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/25/2021 8:26:40 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/22/2021 11:59:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/21/2021 2:29:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 6:22:06 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/19/2021 6:12:48 AM
Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering PR Newswire (US) - 1/15/2021 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 4:16:11 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2021 10:01:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/31/2020 6:01:23 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/31/2020 6:01:15 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences